InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,063.84
(
0.30%
)
Post# of 252588
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

drbio45

Send PM Follow Ignore
Followers 36
Posts 3185
Boards Moderated 0
Alias Born 10/18/2003

drbio45

Re: bladerunner1717 post# 48365

Saturday, 06/09/2007 8:27:38 PM

Saturday, June 09, 2007 8:27:38 PM

Post# of 252588
I understand the patent on Zyflo expires in 2012. Is that correct? If true, would that alter your favorable outlook for CRTX?

Look at the market cap and 4 years of sales in decent quantities still favors the stock at being cheap. Look what happened to viopharam getting a drug that was losing it patent's sales up.

they are working on an R-isomer which would estend patent situation for them

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up